Literature DB >> 19854741

Efficacy of infliximab therapy in two patients with refractory Vogt-Koyanagi-Harada disease.

L Niccoli, C Nannini, E Cassarà, G Gini, I Lenzetti, F Cantini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19854741     DOI： 10.1136/bjo.2008.153981

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

Review 1.  Noninfectious uveitis in the Asia-Pacific region.

Authors:  Yung-Ray Hsu; Jerry Chien-Chieh Huang; Shih-Hwa Chiou; De-Kuang Hwang; Yong Tao; Toshikatsu Kaburaki; Christopher Seungkyu Lee; Tai-Chi Lin; Chih-Chien Hsu
Journal:  Eye (Lond)       Date:  2018-10-15       Impact factor: 3.775

2.  Rituximab in refractory Vogt-Koyanagi-Harada disease.

Authors:  Rosa Dolz-Marco; Roberto Gallego-Pinazo; Manuel Díaz-Llopis
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-07-09

Review 3.  Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.

Authors:  Ioannis Papasavvas; Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

4.  Vogt-Koyanagi-Harada Syndrome: A Diagnostic Conundrum.

Authors:  Anila Hussain; Ritu Khurana
Journal:  Cureus       Date:  2021-12-03

5.  Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-naïve Vogt-Koyanagi-Harada disease patients.

Authors:  Shizhao Yang; Tianyu Tao; Zhaohuai Li; Binyao Chen; Zhaohao Huang; Xiuxing Liu; He Li; Lihui Xie; Wen Feng; Wenru Su
Journal:  Ann Transl Med       Date:  2022-06

6.  Innovations in the diagnosis and management of uveitis: promising research to address unmet patient needs.

Authors:  Steven Yeh; Ye Huang; Joanne Thomas
Journal:  Ann Eye Sci       Date:  2022-03

Review 7.  Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.

Authors:  Marcelo Mendes Lavezzo; Viviane Mayumi Sakata; Celso Morita; Ever Ernesto Caso Rodriguez; Smairah Frutuoso Abdallah; Felipe T G da Silva; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Orphanet J Rare Dis       Date:  2016-03-24       Impact factor: 4.123

8.  Long term treatment with infliximab in pediatric Vogt-Koyanagi-Harada disease.

Authors:  Gustavo A Budmann; Ludmila García Franco; Alejandra Pringe
Journal:  Am J Ophthalmol Case Rep       Date:  2018-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.